More News

01 Apr 2019 Novartis to Acquire IFM Tre to Develop First-In-Class NLRP3 Antagonist Portfolio Targeting Innate Immune System
30 Mar 2019 StrideBio and Takeda Sign Collaboration and License Agreement to Advance Novel Gene Therapies for Neurological Diseases
30 Mar 2019 AstraZeneca and Daiichi Sankyo enter collaboration for novel HER2-targeting antibody-drug conjugate
30 Mar 2019 Boehringer Ingelheim Enhances Oncology R&D with Novel MacroDel Delivery Technology Via Acquisition of ICD Therapeutics
28 Mar 2019 Lilly and ImmuNext Announce Licensing and Research Collaboration
26 Mar 2019 Ichor Medical Systems Announces Collaboration and Research License Agreement with AstraZeneca to Develop DNA-based Monoclonal Antibody Platform
22 Mar 2019 LegoChem Biosciences and Takeda Enter into a Multi-Target Research Collaboration and License Agreement for the Development of Antibody-Drug Conjugates in Immuno-Oncology
21 Mar 2019 Alexion and Affibody Announce Partnership to Co-Develop Anti-FcRn Affibody® Molecule
20 Mar 2019 Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics
20 Mar 2019 Domainex and SpiroChem Enter a Fragment Drug Discovery Partnership
20 Mar 2019 Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases
19 Mar 2019 Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD
19 Mar 2019 Ono Pharmaceutical and twoXAR Announce Drug Discovery Research Collaboration
14 Mar 2019 Merck KGaA, Darmstadt, Germany, Announces Collaboration With Iktos for Generative Artificial Intelligence (AI) Technology
13 Mar 2019 Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca
13 Mar 2019 Flow Pharma, Inc. and OncoImmunity AS partner for the Development of FlowVaxTM Personalized Cancer Vaccines
13 Mar 2019 HitGen and SPARC Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration
11 Mar 2019 Parkinson’s disease: Servier and Oncodesign join forces to investigate new line of research
11 Mar 2019 Stemline In-Licenses Worldwide Rights to Novel Selective RET Inhibitor (SL-1001); Expands Oncology Pipeline
11 Mar 2019 Principia Biopharma Reacquires Rights to Oral Immunoproteasome Program
11 Mar 2019 aTyr Pharma Announces Research Collaboration With Global Biotherapeutics Leader CSL Behring
11 Mar 2019 Bridge Medicines Enters Agreement with Weill Cornell Medicine to Develop a Novel Sphingosine 1-Phosphate (S1P) Receptor Modulator
09 Mar 2019 TaiwanJ Pharmaceuticals Obtained US$26M Deal for Licensing and Co-Development Contract with Newsoara Biopharma on JKB-122 Asian Rights
09 Mar 2019 Xencor Announces Closing of Research Collaboration and License Agreement with Genentech
06 Mar 2019 ReForm Biologics Announces Collaboration Agreement with Astellas Pharma Inc.

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up